These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14104853)

  • 21. Thoughts on relief for atomic bomb survivors since Obama's visit to Hiroshima.
    Nagataki S
    Lancet; 2016 Oct; 388(10054):1878-1879. PubMed ID: 27681099
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of polypharmacy on heart rate variability in older adults at the Hiroshima Atomic Bomb Survivors Recuperation Research Center, Japan.
    Okada M; Okada K; Fujii K
    PLoS One; 2018; 13(12):e0209081. PubMed ID: 30540860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STATISTICAL OBSERVATIONS OF LENTICULAR CHANGES IN SURVIVORS OF THE HIROSHIMA A-BOMB: CLINICAL AND STATISTICAL OBSERVATIONS OF DELAYED EFFECTS.
    INADA GJ; HALL CW
    Am J Ophthalmol; 1965 Feb; 59():216-21. PubMed ID: 14268794
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term epidemiological studies of atomic bomb survivors in Hiroshima and Nagasaki: study populations, dosimetry and summary of health effects.
    Okubo T
    Radiat Prot Dosimetry; 2012 Oct; 151(4):671-3. PubMed ID: 22908354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Excess Risk of Heart Disease Mortality among Hiroshima Atomic Bomb Male Survivors Exposed Near the Hypocenter.
    Hara N; Satoh K; Otani K; Kawakami H; Ohtaki M
    Hiroshima J Med Sci; 2016 Sep; 65(2):45-51. PubMed ID: 29989684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The grave is wide: the Hibakusha of Hiroshima and Nagasaki and the legacy of the Atomic Bomb Casualty Commission and the Radiation Effects Research Foundation.
    O'Malley GF
    Clin Toxicol (Phila); 2016 Jul; 54(6):526-30. PubMed ID: 27158765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid Dysfunction and Autoimmune Thyroid Diseases Among Atomic Bomb Survivors Exposed in Childhood.
    Imaizumi M; Ohishi W; Nakashima E; Sera N; Neriishi K; Yamada M; Tatsukawa Y; Takahashi I; Fujiwara S; Sugino K; Ando T; Usa T; Kawakami A; Akahoshi M; Hida A
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2516-2524. PubMed ID: 28472357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukemia in atomic bomb survivors, Hiroshima and Nagasaki, 1 October 1950--30 September 1966.
    Ishimaru T; Hoshino T; Ichimaru M; Okada H; Tomiyasu T
    Radiat Res; 1971 Jan; 45(1):216-33. PubMed ID: 5275936
    [No Abstract]   [Full Text] [Related]  

  • 29. Leukemia in Hiroshima atomic bomb survivors.
    HEYSSEL R; BRILL AB; WOODBURY LA; NISHIMURA ET; GHOSE T; HOSHINO T; YAMASAKI M
    Blood; 1960 Mar; 15():313-31. PubMed ID: 14401659
    [No Abstract]   [Full Text] [Related]  

  • 30. Atomic bomb and leukemia.
    Ichimaru M; Tomonaga M; Amenomori T; Matsuo T
    J Radiat Res; 1991 Dec; 32 Suppl 2():14-9. PubMed ID: 1823351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [STATISTICAL OBSERVATIONS ON A SURVEY OF ATOMIC BOMB CASUALTIES BEFORE THE ESTABLISHMENT OF THE ATOMIC BOMB MEDICAL TREATMENT LAW (1954-1957). (1)].
    SHIMIZU K
    Nagasaki Igakkai Zasshi; 1963 Dec; 38():SUPPL:27-35. PubMed ID: 14146156
    [No Abstract]   [Full Text] [Related]  

  • 32. High Initial-dose Dependency of Cerebrovascular Disease Mortality among Female Survivors of the Hiroshima Atomic Bomb Exposed in Teens: A Cohort Study, 1970-2010.
    Matsuba J; Otani K; Satoh K; Kawakami H; Ohtaki M
    Hiroshima J Med Sci; 2016 Sep; 65(2):35-43. PubMed ID: 29989683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High incidence of meningioma among Hiroshima atomic bomb survivors.
    Shintani T; Hayakawa N; Hoshi M; Sumida M; Kurisu K; Oki S; Kodama Y; Kajikawa H; Inai K; Kamada N
    J Radiat Res; 1999 Mar; 40(1):49-57. PubMed ID: 10408177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [REPORT OF A SURVEY OF NAGASAKI ATOMIC BOMB CASUALTIES].
    KURIMOTO S
    Nagasaki Igakkai Zasshi; 1963 Dec; 38():SUPPL:56-60. PubMed ID: 14146159
    [No Abstract]   [Full Text] [Related]  

  • 35. [Symposium: Epidemiology of leukemia in Japan. Leukemia in atomic bomb survivors. 1. Hiroshima, 1946-1967].
    Hirose F
    Nihon Ketsueki Gakkai Zasshi; 1968 Oct; 31(5):765-71. PubMed ID: 5753616
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute myelogenous leukemia with monosomy 7 in a Hiroshima survivor 60 years after the atomic bomb.
    Takahashi T; Harada S; Oki M; Yoshimoto M; Tsujisaki M; Maemori M; Sakai H
    Cancer Genet Cytogenet; 2006 Oct; 170(2):182-3. PubMed ID: 17011994
    [No Abstract]   [Full Text] [Related]  

  • 37. [ON BREAST NEOPLASMS IN ATOMIC BOMB CASUALTIES].
    HARANO C; TEZUKA H; FURUKAWA H; DEGUCHI N
    Nagasaki Igakkai Zasshi; 1963 Dec; 38():SUPPL:114-6. PubMed ID: 14146143
    [No Abstract]   [Full Text] [Related]  

  • 38. [FACTOR ANALYSIS OF AGES ATTACKED BY LEUKEMIA IN ATOMIC BOMB CASUALTIES].
    WATANABO M
    Nagasaki Igakkai Zasshi; 1963 Dec; 38():SUPPL:146-9. PubMed ID: 14146149
    [No Abstract]   [Full Text] [Related]  

  • 39. Workshop Report on Atomic Bomb Dosimetry--Review of Dose Related Factors for the Evaluation of Exposures to Residual Radiation at Hiroshima and Nagasaki.
    Kerr GD; Egbert SD; Al-Nabulsi I; Bailiff IK; Beck HL; Belukha IG; Cockayne JE; Cullings HM; Eckerman KF; Granovskaya E; Grant EJ; Hoshi M; Kaul DC; Kryuchkov V; Mannis D; Ohtaki M; Otani K; Shinkarev S; Simon SL; Spriggs GD; Stepanenko VF; Stricklin D; Weiss JF; Weitz RL; Woda C; Worthington PR; Yamamoto K; Young RW
    Health Phys; 2015 Dec; 109(6):582-600. PubMed ID: 26509626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survivors of bombing of Hiroshima 3 years later.
    NOVY FG
    Arch Derm Syphilol; 1950 Mar; 61(3):379-83. PubMed ID: 15404850
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.